Quantifying epidemic risk for a more resilient world
Founded in 2008 by virologist Nathan Wolfe, Metabiota built the Global Epidemic Monitoring and Modeling platform quantifying epidemic risk for governments, insurers, and enterprises. In 2018, Metabiota launched PathogenRX, an epidemic risk insurance product developed with Marsh and Munich Re. The company gained prominence during COVID-19 for early modeling of global spread.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account